Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LQ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,664
Award facts
- Contract value 100% obligated
- $22,663.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp for Xifaxan 550 mg tablets (60-count) valued at $22,663.95 under a firm fixed-price contract. The award was made on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a non-set-aside competitive award, and the place of performance is in Conshohocken, Pennsylvania. Xifaxan is an antibiotic used to treat traveler's diarrhea and hepatic encephalopathy, supporting the Defense Logistics Agency's requirement to supply pharmaceutical products to military and federal healthcare systems.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a subsidiary of Cencora, Inc., Amerisourcebergen serves as a critical pharmaceutical distributor providing a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. The parent company, Cencora, Inc., holds a master IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, establishing the company's significant role in the federal pharmaceutical supply chain across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9LQ2?
SPE2DR26F9LQ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LQ2 worth?
The government has obligated $22,664 on SPE2DR26F9LQ2.
Is contract SPE2DR26F9LQ2 an order under another contract?
Yes. SPE2DR26F9LQ2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LQ2 competed?
The extent of competition for SPE2DR26F9LQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award